Clinical trial
Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion
NCT00040040 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- June 30, 2002
- Completion date
- September 30, 2003
- Enrollment
- 20
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.